Use of radiomic features and support vector machine to distinguish Parkinson's disease cases from normal controls.

Background Parkinson's disease (PD) is an irreversible neurodegenerative disease. The diagnosis of PD based on neuroimaging is usually with low-level or deep learning features, which results in difficulties in achieving precision classification or interpreting the clinical significance. Herein, we aimed to extract high-order features by using radiomics approach and achieve acceptable diagnosis accuracy in PD. Methods In this retrospective multicohort study, we collected 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) images and clinical scale [the Unified Parkinson's Disease Rating Scale (UPDRS) and Hoehn & Yahr scale (H&Y)] from two cohorts. One cohort from Huashan Hospital had 91 normal controls (NC) and 91 PD patients (UPDRS: 22.7±11.7, H&Y: 1.8±0.8), and the other cohort from Wuxi 904 Hospital had 26 NC and 22 PD patients (UPDRS: 20.9±11.6, H&Y: 1.7±0.9). The Huashan cohort was used as the training and test sets by 5-fold cross-validation and the Wuxi cohort was used as another separate test set. After identifying regions of interests (ROIs) based on the atlas-based method, radiomic features were extracted and selected by using autocorrelation and fisher score algorithm. A support vector machine (SVM) was trained to classify PD and NC based on selected radiomic features. In the comparative experiment, we compared our method with the traditional voxel values method. To guarantee the robustness, above processes were repeated in 500 times. Results Twenty-six brain ROIs were identified. Six thousand one hundred and ten radiomic features were extracted in total. Among them 30 features were remained after feature selection. The accuracies of the proposed method achieved 90.97%±4.66% and 88.08%±5.27% in Huashan and Wuxi test sets, respectively. Conclusions This study showed that radiomic features and SVM could be used to distinguish between PD and NC based on 18F-FDG PET images.

[1]  L. Flicker,et al.  18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). , 2017, The Cochrane database of systematic reviews.

[2]  B. Robottom Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression , 2012 .

[3]  U. Rajendra Acharya,et al.  Parkinson's disease: Cause factors, measurable indicators, and early diagnosis , 2018, Comput. Biol. Medicine.

[4]  José Augusto Baranauskas,et al.  How Many Trees in a Random Forest? , 2012, MLDM.

[5]  A. Rahmim,et al.  Investigation of texture quantification parameters for neurological PET image analysis , 2015, 2015 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC).

[6]  Irène Buvat,et al.  Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis , 2014, The Journal of Nuclear Medicine.

[7]  James F. Greenleaf,et al.  Use of gray value distribution of run lengths for texture analysis , 1990, Pattern Recognit. Lett..

[8]  Yong Liu,et al.  Radiomic Features of Hippocampal Subregions in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment , 2018, Frontiers in Aging Neuroscience.

[9]  Issam El-Naqa,et al.  Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer , 2017, Scientific Reports.

[10]  V. Dhawan,et al.  Abnormal Metabolic Network Activity in Parkinson'S Disease: Test—Retest Reproducibility , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[12]  R. Hauser,et al.  Nonmotor symptoms of Parkinson’s disease , 2006, Expert review of neurotherapeutics.

[13]  Hojjat Adeli,et al.  Computer-Aided Diagnosis of Parkinson’s Disease Using Enhanced Probabilistic Neural Network , 2015, Journal of Medical Systems.

[14]  P. Khong,et al.  MRI texture features may predict differentiation and nodal stage of cervical cancer: a pilot study , 2017, Acta radiologica open.

[15]  Antonio P. Strafella,et al.  Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts , 2017, Translational Neurodegeneration.

[16]  A. Kawaguchi,et al.  Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease , 2010, Neuroscience.

[17]  P. Lambin,et al.  Radiomics: the bridge between medical imaging and personalized medicine , 2017, Nature Reviews Clinical Oncology.

[18]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[19]  T. Jiang,et al.  Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature , 2018, European Radiology.

[20]  Torsten Rohlfing,et al.  Combining atlas-based parcellation of regional brain data acquired across scanners at 1.5T and 3.0T field strengths , 2012, NeuroImage.

[21]  T. Watabe,et al.  Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma , 2019, International Journal of Clinical Oncology.

[22]  Belur V. Dasarathy,et al.  Image characterizations based on joint gray level-run length distributions , 1991, Pattern Recognit. Lett..

[23]  Erwan Scornet,et al.  A random forest guided tour , 2015, TEST.

[24]  David Eidelberg,et al.  Metabolic brain networks in translational neurology: Concepts and applications , 2012, Annals of neurology.

[25]  Scott Peltier,et al.  Frontiers in Systems Neuroscience Systems Neuroscience Altered Resting State Cortico-striatal Connectivity in Mild to Moderate Stage Parkinson's Disease Materials and Methods Frequency Content Analysis of the Fmri Bold Signal Comparison of Caudate versus Putamen Functional Connectivity in Controls, , 2022 .

[26]  Y. Guan,et al.  Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging. , 2013, Parkinsonism & related disorders.

[27]  Remco J. Renken,et al.  Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging , 2014, NeuroImage: Clinical.

[28]  D. Oldridge,et al.  MRI features predict survival and molecular markers in diffuse lower-grade gliomas , 2017, Neuro-oncology.

[29]  Ehsan Adeli,et al.  Joint feature-sample selection and robust diagnosis of Parkinson's disease from MRI data , 2016, NeuroImage.

[30]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[31]  D. Eidelberg,et al.  Network imaging biomarkers: insights and clinical applications in Parkinson's disease , 2018, The Lancet Neurology.

[32]  Martin J. McKeown,et al.  Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson's disease , 2015, Front. Neurosci..

[33]  Jiehui Jiang,et al.  Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment , 2019, Therapeutic advances in neurological disorders.

[34]  Benjamin S Aribisala,et al.  Assessing the Performance of Atlas-Based Prefrontal Brain Parcellation in an Aging Cohort , 2013, Journal of computer assisted tomography.

[35]  S. Lewis,et al.  Biomarkers and Parkinson's disease. , 2004, Brain : a journal of neurology.

[36]  W. Jost,et al.  [Nonmotor symptoms in Parkinson's disease]. , 2017, Der Nervenarzt.

[37]  Mary M. Galloway,et al.  Texture analysis using gray level run lengths , 1974 .

[38]  Wei Lin,et al.  Use of Overlapping Group LASSO Sparse Deep Belief Network to Discriminate Parkinson's Disease and Normal Control , 2019, Front. Neurosci..

[39]  E. Louis,et al.  Emergence of Parkinson's disease in essential tremor: A study of the clinical correlates in 53 patients , 2008, Movement disorders : official journal of the Movement Disorder Society.

[40]  B. Choe,et al.  Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. , 2004, European journal of radiology.

[41]  V. Dhawan,et al.  The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease. , 2017, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[42]  B. Turgut,et al.  Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer , 2019, Nuclear medicine communications.

[43]  Andre Dekker,et al.  Radiomics: the process and the challenges. , 2012, Magnetic resonance imaging.

[44]  Z. J. Wang,et al.  Joint amplitude and connectivity compensatory mechanisms in Parkinson's disease , 2010, Neuroscience.

[45]  David J. Brooks,et al.  Imaging biomarkers in Parkinson's disease , 2011, Progress in Neurobiology.

[46]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[47]  Bernard Fertil,et al.  Shape and Texture Indexes Application to Cell nuclei Classification , 2013, Int. J. Pattern Recognit. Artif. Intell..

[48]  J. Assmus,et al.  Importance of motor vs. non-motor symptoms for health-related quality of life in early Parkinson's disease. , 2013, Parkinsonism & related disorders.

[49]  J R Moeller,et al.  Metabolic correlates of pallidal neuronal activity in Parkinson's disease. , 1997, Brain : a journal of neurology.

[50]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[51]  D. Brooks PET studies on the early and differential diagnosis of Parkinson's disease , 1993, Neurology.

[52]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[53]  Hong Yu,et al.  Role of hyperactive cerebellum and motor cortex in Parkinson's disease , 2007, NeuroImage.

[54]  Robert King,et al.  Textural features corresponding to textural properties , 1989, IEEE Trans. Syst. Man Cybern..

[55]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[56]  J. Roerdink,et al.  Validation of parkinsonian disease‐related metabolic brain patterns , 2013, Movement disorders : official journal of the Movement Disorder Society.

[57]  Elmar Nöth,et al.  Characterisation of voice quality of Parkinson's disease using differential phonological posterior features , 2017, Comput. Speech Lang..

[58]  Xian Liu,et al.  Enhanced Functional Connectivity between Putamen and Supplementary Motor Area in Parkinson’s Disease Patients , 2013, PloS one.

[59]  Laura K. Teune,et al.  FDG- PET Imaging in Neurodegenerative Brain Diseases , 2013 .

[60]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[61]  Hucheng Zhou,et al.  Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease , 2019, Front. Neurosci..

[62]  Philippe Lambin,et al.  Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[63]  Sabina Sonia Tangaro,et al.  Complex networks reveal early MRI markers of Parkinson's disease , 2018, Medical Image Anal..

[64]  P. Payoux,et al.  Diagnostic and prognostic value of amyloid PET textural and shape features: comparison with classical semi-quantitative rating in 760 patients from the ADNI-2 database , 2019, Brain Imaging and Behavior.

[65]  Xuemei Huang,et al.  The Role of the Cerebellum in the Pathophysiology of Parkinson's Disease , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[66]  Marios Politis,et al.  Neuroimaging in Parkinson disease: from research setting to clinical practice , 2014, Nature Reviews Neurology.

[67]  V. Pérez-García,et al.  Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate , 2018, Annals of Nuclear Medicine.

[68]  Lin Zhu,et al.  PET/SPECT imaging agents for neurodegenerative diseases. , 2014, Chemical Society reviews.

[69]  L. Sanders,et al.  Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease , 2018, Neurobiology of Disease.

[70]  N. Michoux,et al.  Texture analysis on MR images helps predicting non-response to NAC in breast cancer , 2015, BMC Cancer.

[71]  A. Rahmim,et al.  Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images , 2017, NeuroImage: Clinical.

[72]  R. Mailman,et al.  Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease , 2011, Neuroscience.

[73]  Anna Barnes,et al.  FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.

[74]  David Eidelberg,et al.  Assessment of the progression of Parkinson's disease: a metabolic network approach , 2007, The Lancet Neurology.